GENEVA, Sept. 24 -- PRINCIPIA BIOPHARMA INC. filed a patent application (US2025/020419) for “FORMULATIONS OF 2-[(3R)-2-[4-AMINO-3-(2-FLUORO-4-PHENOXY- PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4- METHYL-4[4-(OXETAN-3-YL)PIPERAZIN-1-YL]-PENT-2-ENENITRILE”. With publication no. WO/2025/199134, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: A61K 9/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....